Analyzing And Valuing Molina Healthcare As A Solid Company
Portfolio Pulse from
Molina Healthcare has significantly increased its Medicaid membership by 49.55% from 2019 to 2023. The Medicaid program, which constitutes 91% of Molina's revenues, is projected to grow annually by 5.2% until 2032. A DCF valuation suggests Molina is undervalued by 82.37% in a baseline scenario and 3.02% in a pessimistic scenario.
November 13, 2024 | 10:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Molina Healthcare's Medicaid membership grew by 49.55% from 2019 to 2023, with Medicaid making up 91% of its revenues. The program is expected to grow 5.2% annually until 2032. DCF valuation indicates the stock is undervalued by 82.37% in a baseline scenario.
The significant increase in Medicaid membership and the projected growth of Medicaid revenues are positive indicators for Molina Healthcare. The DCF valuation showing the stock is undervalued by a large margin suggests potential for stock price appreciation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100